1 Bossy-Wetzel E, Bakiri L, Yaniv M. Induction of apoptosis by the transcription factor c-Jun[J]. EMBO J,1997,16(7):1695~1709.2 Bozec A, Bakiri L, Hoebertz A, et al. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia[J]. Nature,2008,454(7201):221~225.3 Bozec A, Bakiri L, Jimenez M, et al. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production[J]. J Cell Biol,2010,190(6):1093~1106.4 Bozec A, Bakiri L, Jimenez M, et al. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism[J]. Journal of Cell Science,2013,126(23):5432~5440.5 Carrasco D, Bravo R. Tissue-specific expression of the fos-related transcription factor Fra-2 during mouse development[J]. Oncogene,1995,10(6):1069~1079.6 Chinenov Y, Kerppola T K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity[J]. Oncogene,2001,20(19):2438~2452.7 Eferl R, Wagner E F. AP-1:A double-edged sword in tumorigenesis[J]. Nat Rev Cancer, 2003, 3(11):859~868.8 Eferl R, Zenz R, Theussl H C, et al. Simulataneous generation of Fra-2 conditional and Fra-2 knock-out mice[J]. Genesis, 2007, 45(7):447~451.9 Eferl R, Hasselblatt P, Rath M, et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1[J].Proc Natl Acad Sci USA,2008, 105(30):10525~10530.10 Fernandes K A, Harder J M, Kim J, et al. Jun regulates early transcriptional responses to axonal injury in retinal ganglion cells[J]. Experimental Eye Research,2013,112:106~117.11 Foletta V C, Sonobe M H, Suzuki T, et al. Cloning and characterisation of the mouse Fra-2 gene[J]. Oncogene, 1994, 9(11):3305~3311.12 Johnson R S, van Lingen B, Papaioannou V E, et al. A null mutation at the c-Jun locus causes embryonic lethality and retarded cell growth in culture[J]. Genes Dev,1993, 7(7B):1309~1317.13 Karin M L, Stanislava J, Ines W. Role of Fra-2 in breast cancer:Influence on tumor cell invasion and motility[J]. Breast Cancer Res Treat, 2008, 107(3):337~347.14 Karreth F, Hoebertz A, Scheuch H, et al. The AP1 transcription factor Fra-2 is required for efficient cartilage development[J]. Development, 2004, 131(22):5717~5725.15 Kharman-Biz A, Gao H, Ghiasvand R, et al. Expression of activator protein-1 (AP-1) family members in breast cancer[J]. BMC Cancer,2013, 13:441.16 Maurer B, Reich N, Juengel A, et al. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis[J]. Ann Rheum Dis,2012, 71(8):1382~1387.17 Maurer B, Distler J H, Distler O. The Fra-2 transgenic mouse model of systemic sclerosis[J]. Vascul Pharmacology, 2013, 58(3):194~201.18 McHenry J Z, Leon A, Matthaei K I, et al. Overexpression of Fra-2 in transgenic mice perturbs normal eye development[J]. Oncogene, 1998, 17:1131~1140.19 Molven A, Houge G, Berger R. Chromosomal assignment of the human gene encoding the Fos-related antigen-2 (Fra2) to chromosome 2p22-p23[J]. Genomics, 1996, 38(1):72~75.20 Nakayama T, Higuchi T, Oiso N, et al. Expression and function of Fra2/Jund in cutaneous T-cell lymphomas[J]. Anticancer Res, 2012, 32(4):1367~1373.21 Ochi Y, Koizumi T, Kobayashi S, et al. Analysis of IL-2 gene regulation in c-fos transgenic mice,evidence for an enhancement of IL-2 expression in splenic T cells stimulated via TCR/CD3 complex[J]. J Immunol, 1994, 153(8):3485~3490.22 Phuchareon J, Tokuhisa T. Deregulated c-Fos/AP-1 modulates expression of the cyclin and the cdk gene in splenic B cells stimulated with lipopolysaccharide[J]. Immunobiology, 1995, 92(2):203~208.23 Poirier C, Lalouette A, Foletta V C, et al. The gene encoding the Fos-related antigen 2 (Fosl2) maps to mouse chromosome 5[J]. Mamm Genome,1997,8(3):223.24 Reich N, Maurer B, Akhmetshina A, et al. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis[J]. Arthritis Rheum, 2010, 62(1):280~290.25 Robinson G A. Changes in the expression of transcription factors ATF-2 and Fra-2 after axotomy and during regeneration in rat retinal ganglion cells[J]. Brain Research Molecular Brain Research,1996,41(1~2):57~64.26 Tulchinsky E. Fos family members:Regulation,structure and role in oncogenic transformation[J]. Histology and Histopathology, 2000, 15(3):921~928.27 Udalova I A, Kwiatkowski D. Interaction of AP-1 with a cluster of NF-kappa B binding elements in the human TNF promoter region[J]. Biochem Biophys Res Commun, 2001,289(1):25~33.28 Wrann C D, Eguchi J, Bozec A, et al. Fosl2 promotes leptin gene expression in human and mouse adipocytes[J]. J Clin Invest,2012, 122(3):1010~1021. |